GNPX

Genprex Inc

NASDAQ: GNPX · HEALTHCARE · BIOTECHNOLOGY

$3.35

+0.00% today

Updated 2026-09-11

Market cap

$2.88M

P/E ratio

0.10

P/S ratio

—

EPS (TTM)

$34.43

Dividend yield

—

52W range

$3 – $1,210

Volume

0.3M

Market cap

$2.88M

P/E ratio

0.10

P/S ratio

—

EPS (TTM)

$34.43

Dividend yield

—

52W range

$3 – $1,210

Volume

0.3M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.0

Quality

3.0

Profitability

6.7

Valuation

3/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →251 stocks currently score above 75

Price targets

Analyst target

$7.50

+123.88%

12-Month target

$4.25

+26.87%

Intrinsic (DCF)

—

Margin of safety

—

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Piotroski 3/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-5.14M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-23.74M	$-30.86M	$-21.11M	$-16.23M	$-4.45M
EPS	—	—	—	—	$34.43
Free cash flow	$-17.78M	$-24.81M	$-17.15M	$-15.31M	$-5.14M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
GNPX	$2.88M	26	4.3	3.0	6.7	6.0	—	Avoid
LLY	$994.92B	76	9.3	10.0	5.0	6.0	—	Strong Buy
JNJ	$640.02B	59	4.7	8.5	2.7	6.0	-88.93%	Buy
ABBV	$454.36B	73	6.7	8.5	4.0	5.0	-69.36%	Strong Buy
MRK	$355.10B	36	4.0	4.5	2.0	5.0	-73.74%	Hold
UNH	$340.27B	62	7.3	5.5	4.7	6.0	-16.10%	Buy

Smart narrative

Genprex Inc trades at $3.35. representing a P/E of 0.10x trailing earnings. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score.

Frequently asked questions

What is Genprex Inc's stock price?

Genprex Inc (GNPX) trades at $3.35, on a P/E of 0.1x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.

Is Genprex Inc overvalued?

Genprex Inc carries a Smart Value Score of 26/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Genprex Inc (GNPX)?

The 12-month analyst consensus target is $7.50, about 123.9% above the current $3.35. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-160.80%

Beta-0.89

50D MA$7.36

200D MA$32.21

Shares out0.00B

Float0.00B

Short ratio—

Avg volume0.3M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

GNPX vs LLY →GNPX vs JNJ →GNPX vs ABBV →Stock screener →